TY - JOUR
T1 - Considerations and future research directions for E-cigarette warnings—findings from expert interviews
AU - Wackowski, Olivia A.
AU - Hammond, David
AU - O’Connor, Richard J.
AU - Strasser, Andrew A.
AU - Delnevo, Cristine D.
N1 - Funding Information:
This work was supported by a grant from the National Cancer Institute and the Food & Drug Administration Center for Tobacco Products (K01CA189301). Thank you to Suzanne Millward for help in implementation of study activities and preliminary data analysis.
PY - 2017/7/14
Y1 - 2017/7/14
N2 - Tobacco warning labels are important sources of risk information but research historically has been cigarette-centric. This qualitative study aimed to inform future direction and research on warnings for e-cigarettes. Between June and August 2016, we conducted interviews with 10 researchers with expertise in tobacco warning label research. Interviewees were registrants of a 2016 National Cancer Institute grantee meeting on tobacco warnings. Several participants agreed that the Food and Drug Administration’s new nicotine addiction warning for e-cigarettes could be informative but that it might not resonate with young people. Many agreed that more than one warning would be important as e-cigarette science evolves and that research on additional warning themes (e.g., nicotine exposure, harmful constituents) and execution styles (including use of pictorials) was important. Participants were somewhat mixed about the use of reduced-risk messages within e-cigarette warnings, but agreed that research on how to communicate about cigarette/e-cigarette relative risks was needed. Overall, more research is needed on tobacco warnings for non-cigarette products, including on the message content, placement, execution and potential impact on audiences’ product knowledge, risk perceptions and use intentions. This is particularly needed for products such as e-cigarettes which may have harm-reduction potential relative to cigarettes and require unique considerations.
AB - Tobacco warning labels are important sources of risk information but research historically has been cigarette-centric. This qualitative study aimed to inform future direction and research on warnings for e-cigarettes. Between June and August 2016, we conducted interviews with 10 researchers with expertise in tobacco warning label research. Interviewees were registrants of a 2016 National Cancer Institute grantee meeting on tobacco warnings. Several participants agreed that the Food and Drug Administration’s new nicotine addiction warning for e-cigarettes could be informative but that it might not resonate with young people. Many agreed that more than one warning would be important as e-cigarette science evolves and that research on additional warning themes (e.g., nicotine exposure, harmful constituents) and execution styles (including use of pictorials) was important. Participants were somewhat mixed about the use of reduced-risk messages within e-cigarette warnings, but agreed that research on how to communicate about cigarette/e-cigarette relative risks was needed. Overall, more research is needed on tobacco warnings for non-cigarette products, including on the message content, placement, execution and potential impact on audiences’ product knowledge, risk perceptions and use intentions. This is particularly needed for products such as e-cigarettes which may have harm-reduction potential relative to cigarettes and require unique considerations.
KW - Health communication
KW - Risk communication
KW - Risk perceptions
KW - Warnings
KW - e-cigarettes
UR - http://www.scopus.com/inward/record.url?scp=85025080589&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85025080589&partnerID=8YFLogxK
U2 - 10.3390/ijerph14070781
DO - 10.3390/ijerph14070781
M3 - Article
C2 - 28708124
AN - SCOPUS:85025080589
VL - 14
JO - International Journal of Environmental Research and Public Health
JF - International Journal of Environmental Research and Public Health
SN - 1661-7827
IS - 7
M1 - 781
ER -